PaCS is a novel cytoplasmic structure containing functional proteasome and inducible by cytokines/trophic factors

PLoS One. 2013 Dec 17;8(12):e82560. doi: 10.1371/journal.pone.0082560. eCollection 2013.

Abstract

A variety of ubiquitinated protein-containing cytoplasmic structures has been reported, from aggresomes to aggresome-like induced structures/sequestosomes or particle-rich cytoplasmic structures (PaCSs) that we recently observed in some human diseases. Nevertheless, the morphological and cytochemical patterns of the different structures remain largely unknown thus jeopardizing their univocal identification. Here, we show that PaCSs resulted from proteasome and polyubiquitinated protein accumulation into well-demarcated, membrane-free, cytoskeleton-poor areas enriched in glycogen and glycosaminoglycans. A major requirement for PaCS detection by either electron or confocal microscopy was the addition of osmium to aldehyde fixatives. However, by analyzing living cells, we found that proteasome chymotrypsin-like activity concentrated in well-defined cytoplasmic structures identified as PaCSs by ultrastructural morphology and immunocytochemistry of the same cells. PaCSs differed ultrastructurally and cytochemically from sequestosomes which may coexist with PaCSs. In human dendritic or natural killer cells, PaCSs were induced in vitro by cytokines/trophic factors during differentiation/activation from blood progenitors. Our results provide evidence that PaCS is indeed a novel distinctive cytoplasmic structure which may play a critical role in the ubiquitin-proteasome system response to immune, infectious or proneoplastic stimuli.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COS Cells
  • Caco-2 Cells
  • Cells, Cultured
  • Chlorocebus aethiops
  • Cytokines / pharmacology*
  • Cytoplasmic Structures / drug effects*
  • Cytoplasmic Structures / metabolism*
  • Cytoplasmic Structures / ultrastructure
  • Dendritic Cells / drug effects
  • Dendritic Cells / metabolism
  • Dendritic Cells / ultrastructure
  • HL-60 Cells
  • HeLa Cells
  • Humans
  • Intercellular Signaling Peptides and Proteins / pharmacology*
  • Jurkat Cells
  • Proteasome Endopeptidase Complex / metabolism*
  • Up-Regulation / drug effects

Substances

  • Cytokines
  • Intercellular Signaling Peptides and Proteins
  • Proteasome Endopeptidase Complex

Grants and funding

This work was supported by grants from the Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo (Ricerca Finalizzata RF-2010-2310098), from the Italian Ministry for University and Research (Progetto di Ricerca di Interesse Nazionale 2009A37C8C_002 to VR) and from Fondazione Cariplo (grants n. 2009-2532 to ES and n. 2011-0485 to VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.